Early detection of patients with a poor response to vitamin K antagonists: the clinical impact of individual time within target range in patients with heart disease

被引：13
作者：
Veeger, N. J. G. M.
Piersma-Wichers, M.
Hillege, H. L.
Crijns, H. J. G. M.
Van der Meer, J.
机构：
[1] Univ Groningen, Univ Med Ctr Groningen, Trial Coordinat Ctr, NL-9700 RB Groningen, Netherlands
[2] Univ Groningen, Univ Med Ctr Groningen, Dept Haematol, Div Haemostasis Thrombosis & Rheol, NL-9700 RB Groningen, Netherlands
[3] Univ Groningen, Univ Med Ctr Groningen, Thrombosis Serv, NL-9700 RB Groningen, Netherlands
[4] Univ Hosp Maastricht, Dept Cardiol, Maastricht, Netherlands
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2006年 / 4卷 / 07期
关键词：
D O I：
10.1111/j.1538-7836.2006.01997.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1625 / 1627
页数：3
相关论文
共 12 条
[1]   The pharmacology and management of the vitamin K antagonists [J].
Ansell, J ;
Hirsh, J ;
Poller, L ;
Bussey, H ;
Jacobson, A ;
Hylek, E .
CHEST, 2004, 126 (03) :204S-233S
[2]   Oral anticoagulation after myocardial infarction [J].
Arnesen, H .
THROMBOSIS RESEARCH, 2003, 109 (04) :163-170
[3]   Optimal intensity of oral anticoagulant therapy after myocardial infarction [J].
Azar, AJ ;
Cannegieter, SC ;
Deckers, JW ;
Briet, E ;
vanBergen, PFMM ;
Jonker, JJC ;
Rosendaal, FR .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 27 (06) :1349-1355
[4]   High intensity of oral anticoagulant therapy in patients with cerebral haemorrhage: Cause or consequence of the bleeding? [J].
Cannegieter, SC ;
Rosendaal, FR ;
Bollen, ELEM ;
Briet, E .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 96 (03) :497-499
[5]   Oral anticoagulant treatment in patients with mechanical heart valves: how to reduce the risk of thromboembolic and bleeding complications [J].
Cannegieter, SC ;
Torn, M ;
Rosendaal, FR .
JOURNAL OF INTERNAL MEDICINE, 1999, 245 (04) :369-374
[6]   Comparison of control and stability of oral anticoagulant therapy using acenocoumarol versus. phenprocoumon [J].
Fihn, SD ;
Gadisseur, AAP ;
Pasterkamp, E ;
van der Meer, FJM ;
Breukink-Engbers, WGM ;
Geven-Boere, LM ;
van Meegen, E ;
de Vries-Goldschmeding, H ;
Antheunissn-Anneveld, I ;
van't Hoff, R ;
Harderman, D ;
Smink, M ;
Rosendaal, FR .
THROMBOSIS AND HAEMOSTASIS, 2003, 90 (02) :260-266
[7]   Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation [J].
Hylek, EM ;
Go, AS ;
Chang, YC ;
Jensvold, NG ;
Henault, LE ;
Selby, JV ;
Singer, DE .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (11) :1019-1026
[8]   Hemorrhagic complications of anticoagulant treatment [J].
Levine, MN ;
Raskob, G ;
Beyth, RJ ;
Kearon, C ;
Schulman, S .
CHEST, 2004, 126 (03) :287S-310S
[9]  
ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236
[10]   Antithrombotic therapy in vaivular heart disease - Native and prosthetic [J].
Salem, DN ;
Stein, PD ;
Al-Ahmad, A ;
Bussey, HI ;
Horstkotte, D ;
Miller, N ;
Pauker, SG .
CHEST, 2004, 126 (03) :457S-482S
12